TY - JOUR
TI - A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer
AU - Fried, G
AU - Zidan, J
AU - Epelbaum, R
AU - Karen-Rosenberg, S
AU - Basher, W
AU - Steckelman, I
AU - Kogan, F
AU - Haim, N
JO - EUROPEAN JOURNAL OF CANCER
PY - 2002
VL - 38
TODO - null
SP - S69--S70
PB - Elsevier Science Publishing Company, Inc.
SN - null
TODO - null
TODO - null
TODO - null
ER -